A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy

[1]  Norma E. Conner,et al.  Advances and Challenges , 2016, The American journal of hospice & palliative care.

[2]  Masami Watanabe,et al.  Synergistic anti‐pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf‐3 protein and peripheral blood mononuclear cells , 2015, Journal of gastroenterology and hepatology.

[3]  Masami Watanabe,et al.  Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy , 2015, Clinical and translational science.

[4]  I. Date,et al.  [Molecular-Targeted Drug Therapy for Glioma Angiogenesis and Invasion]. , 2015, No shinkei geka. Neurological surgery.

[5]  S. Kanazawa,et al.  Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy , 2015, Clinical Medicine Insights. Oncology.

[6]  K. Fujii,et al.  Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma , 2014, Gene Therapy.

[7]  M. Sakaguchi,et al.  A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector , 2013, Oncology reports.

[8]  Masami Watanabe,et al.  Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review) , 2013, Oncology letters.

[9]  I. Date,et al.  Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme , 2013, Neurologia medico-chirurgica.

[10]  E. Chiocca,et al.  The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus , 2013, Cancer Gene Therapy.

[11]  H. Yamada,et al.  A novel gene expression system for detecting viable bladder cancer cells. , 2012, International journal of oncology.

[12]  K. Ochiai,et al.  Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging. , 2011, Oncology reports.

[13]  I. Date,et al.  Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.

[14]  Y. Naomoto,et al.  Adenovirus-mediated cancer gene therapy and virotherapy (Review). , 2009, International journal of molecular medicine.

[15]  S. Kyo,et al.  A simple biological imaging system for detecting viable human circulating tumor cells. , 2009, The Journal of clinical investigation.

[16]  M. Sakaguchi,et al.  Down‐regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene‐therapeutic overexpression of REIC/Dkk‐3 , 2009, International journal of cancer.

[17]  M. Sakaguchi,et al.  Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. , 2009, International journal of oncology.

[18]  M. Sakaguchi,et al.  Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. , 2008, Cancer research.

[19]  H. Mure,et al.  REIC/Dkk-3 induces cell death in human malignant glioma. , 2008, Neuro-oncology.

[20]  R. Weissleder,et al.  Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. , 2007, Journal of the National Cancer Institute.

[21]  M. Gilbert,et al.  Molecularly targeted therapies for malignant gliomas: advances and challenges , 2007, Expert review of anticancer therapy.

[22]  M. Sakaguchi,et al.  REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. , 2007, International journal of molecular medicine.

[23]  Keerang Park,et al.  Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells. , 2006, Oncology reports.

[24]  M. Sakaguchi,et al.  Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. , 2005, Cancer research.

[25]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[26]  Joon-Seok Song.  Enhanced Expression of Apoptin by the Myc–Max Binding Motif and SV40 Enhancer for SCLC Gene Therapy , 2005, Bioscience, biotechnology, and biochemistry.

[27]  Y. Wong,et al.  Id-1 expression and cell survival , 2004, Apoptosis.

[28]  D. Dean,et al.  Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature , 2003, Gene Therapy.

[29]  T. Mayumi,et al.  Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[30]  M. Sakaguchi,et al.  Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. , 2001, Biochemical and biophysical research communications.

[31]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[32]  M. Sakaguchi,et al.  A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. , 2000, Biochemical and biophysical research communications.

[33]  T. Ichikawa,et al.  Integrin inhibitor suppresses bevacizumab-induced glioma invasion , 2014 .

[34]  I. Date,et al.  Cilengitide treatment for malignant glioma: current status and future direction. , 2012, Neurologia medico-chirurgica.